# Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

> **NCT06284876** · PHASE3 · RECRUITING · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 416 (estimated)

## Conditions studied

- Peptic Ulcer

## Interventions

- **DRUG:** Ilaprazole
- **DRUG:** Lansoprazole
- **DRUG:** Ilaprazole Placebo
- **DRUG:** Lansoprazole Placebo

## Key facts

- **NCT ID:** NCT06284876
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-23
- **Primary completion:** 2026-08-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 416 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06284876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06284876, "Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06284876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*